Birdwatch Note Rating
2023-11-07 19:00:51 UTC - HELPFUL
Rated by Participant: 3C24DD8CB1AD48565B4E2F0C7946384AF179C3B9D5E60A0053C8F76439A93651
Participant Details
Original Note:
This info is outdated & inaccurate. Following publication of new data looking at Remdesivir effects on hospitalization the WHO updated guidance. WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator
All Note Details